Illness	Number of cases
Other malignant neoplasms of skin (C44.3)	157
Erysipelas (A46)	121
Other malignant neoplasms of skin (C44.4)	59
(C44.59)	21
Other dermatitis - Other specified dermatitis (L30.8)	20
Atopic dermatitis (L20.8)	19
Zoster herpes zoster (B02.3)	18
Psoriasis vulgaris (L40.0)	18
Adverse effects not elsewhere classified (T78.2)	18
Other malignant neoplasms of skin (C44.7)	17

Top 10 treatments

Treatment	Number
Skin grafting from the area around the wound (5-903.04)	10
Extensive surgical removal of diseased tissue from the skin or subcutaneous tissues (5-895.34)	6
Surgical removal or destruction of diseased tissue in the nose (5-212.1)	4
Temporary covering of soft tissue injuries with skin or artificial skin (5-916.24)	4
Taking a tissue sample (biopsy) of the facial skin without surgical incision (1-415)	0
Taking a tissue sample (biopsy) of skin or subcutaneous tissues without surgical incision (1-490.1)	0
Surgical removal of diseased tissue from the skin or subcutaneous tissues (5-894.10)	0
Extensive surgical removal of diseased tissue from the skin or subcutaneous tissues (5-895.24)	0
Extensive surgical removal of diseased tissue from the skin or subcutaneous tissues (5-895.37)	0
(5-895.3B)	0

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 3400

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01
CQ06	Weiterführende standortbezogene Informationen unter: www.perinatalzentren.org
CQ27

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
128	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
97	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
97	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Student training (clinical traineeship / internship year)
Participation in multi-centre phase III/IV studies
Project-related cooperation with colleges and universities
Lectureships / teaching posts at universities of applied sciences
Lectureships / teaching posts at colleges and universities
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Editors of scientific journals/textbooks
Doctoral supervision
Participation in multi-centre Phase I/II studies

Training

No.	Training in other healing professions	Comment
HB05	Medical technical radiology assistant (MTRA) (m/f)
HB07	Surgical technical assistant (m/f)
HB10	Midwife (m/f)
HB15	Anaesthesia technical assistant (m/f)
HB18	Emergency paramedics (m/f) (training period 3 years)	Praxispartner
HB19	Nursing professionals	inkl. pädiatrischer Vertiefung
HB17	Auxiliary nurse (m/f)
HB03	Physical therapist / physiotherapist (m/f)	Praxispartner
HB06	Occupational therapist (m/f)	Praxispartner
HB09	Speech therapist (m/f)	Praxispartner